Gene · 2358
Papers3,281
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,281
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Formyl peptide receptor 2 regulates dendritic cell metabolism and Th17 cell differentiation during neuroinflammation. | Front Immunol | 2024 | 39148732 | PubTator, text mining | PubMed |
| Increased expression of formyl peptide receptor-1 by basophils from patients with mastocytosis. | J Allergy Clin Immunol Glob | 2024 | 39148513 | PubTator, text mining | PubMed |
| Long-Term Dietary Consumption of Grapes Affects Kidney Health in C57BL/6J Mice. | Nutrients | 2024 | 39064752 | PubTator, text mining | PubMed |
| Transcriptome Study in Sicilian Patients with Autism Spectrum Disorder. | Biomedicines | 2024 | 39061976 | PubTator, text mining | PubMed |
| Signaling by neutrophil G protein-coupled receptors that regulate the release of superoxide anions. | J Leukoc Biol | 2024 | 39056275 | PubTator, text mining | PubMed |
| Integrative analysis of bulk and single-cell RNA sequencing reveals the gene expression profile and the critical signaling pathways of type II CPAM. | Cell Biosci | 2024 | 39026356 | PubTator, text mining | PubMed |
| Abnormal expression of oxylipins and related synthesizing/signaling pathways in inflammatory bowel diseases. | Prostaglandins Leukot Essent Fatty Acids | 2024 | 38991597 | PubTator, text mining | PubMed |
| Identification of diagnostic signature and immune microenvironment subtypes of venous thromboembolism. | Cytokine | 2024 | 38945040 | PubTator, text mining | PubMed |
| Post-treatment with Resolvin D1 attenuates pulmonary hypertension by inhibiting endothelial-to-mesenchymal transition. | Biomed Pharmacother | 2024 | 38908199 | PubTator, text mining | PubMed |
| LL37/FPR2 regulates neutrophil mPTP promoting the development of neutrophil extracellular traps in diabetic retinopathy. | FASEB J | 2024 | 38842874 | PubTator, text mining | PubMed |
| Advances in the Chemistry and Biology of Specialised Pro-Resolving Mediators (SPMs). | Molecules | 2024 | 38792095 | PubTator, text mining | PubMed |
| Formyl-Peptide Receptor 2 Signaling Modulates SLC7A11/xCT Expression and Activity in Tumor Cells. | Antioxidants (Basel) | 2024 | 38790657 | PubTator, text mining | PubMed |
| Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis. | Thromb J | 2024 | 38654303 | PubTator, text mining | PubMed |
| Differential gene expression and miRNA regulatory network in coronary slow flow. | Sci Rep | 2024 | 38600259 | PubTator, text mining | PubMed |
| Role of formyl peptide receptor 2 in steatosis of L02 cells exposed to Mono-(2-ethylhexyl) phthalate. | Environ Toxicol | 2024 | 38598732 | PubTator, text mining | PubMed |
| The role of FPR2-mediated ferroptosis in formyl peptide-induced acute lung injury against endothelial barrier damage and protective effect of the mitochondria-derived peptide MOTS-c. | Int Immunopharmacol | 2024 | 38527401 | PubTator, text mining | PubMed |
| Anterior cingulate cross-hemispheric inhibition via the claustrum resolves painful sensory conflict. | Commun Biol | 2024 | 38491200 | PubTator, text mining | PubMed |
| Aquaporin-8 promotes human dermal fibroblasts to counteract hydrogen peroxide-induced oxidative damage: A novel target for management of skin aging. | Open Life Sci | 2024 | 38465340 | PubTator, text mining | PubMed |
| Anti-inflammatory actions of aspirin-triggered resolvin D1 (AT-RvD1) in bronchial epithelial cells stimulated by cigarette smoke extract. | Prostaglandins Other Lipid Mediat | 2024 | 38460760 | PubTator, text mining | PubMed |
| Formyl Peptide Receptor 2-Dependent cPLA2 and 5-LOX Activation Requires a Functional NADPH Oxidase. | Antioxidants (Basel) | 2024 | 38397818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2358/papers?page=9